Literature DB >> 7515757

Cytomorphological, cytogenetic, and molecular biological characterization of four new human renal carcinoma cell lines of the clear cell type.

C D Gerharz1, U Ramp, J Olert, R Moll, S Störkel, N Marx, H E Gabbert.   

Abstract

Four new permanent cell lines (RCC-A, -B, -C, and -D) derived from different human renal cell carcinomas of the clear cell type were established in tissue culture. The cell lines displayed characteristic differences in cell size and shape, which allowed individual identification by phase contrast microscopy. Ultrastructurally, the cell lines exhibited varying amounts of cytoplasmatic glycogen and lipid. Immunohistochemistry revealed co-expression of vimentin and cytokeratin in all cell lines. The mean population doubling time ranged from 27 h (RCC-A) to 104 h (RCC-D). RCC-B and -C cells produced slowly growing tumours after heterotransplantation into nude mice, whereas RCC-A and RCC-D cells were non-tumorigenic. The modal chromosome number was either near-diploid (RCC-A, -B, and -C) or near triploid (RCC-D). Clonal abnormalities affecting the short arm of chromosome 3 were seen in all cell lines. Northern blot analysis revealed no expression of the proto-oncogenes c-fos, c-ros, and c-mos, whereas c-Ki-ras expression was observed in all cell lines. Expression of c-myc was observed in RCC-A, RCC-B, and RCC-D cells, whereas c-raf expression could be detected in RCC-B and RCC-D. Tumour suppressor gene p53 mRNA was observed in the cell line RCC-D.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7515757     DOI: 10.1007/bf00190563

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  39 in total

1.  Epidermal growth factor receptor gene expression in normal human kidney and renal cell carcinoma.

Authors:  E R Sargent; L G Gomella; A Belldegrun; W M Linehan; A Kasid
Journal:  J Urol       Date:  1989-11       Impact factor: 7.450

2.  Infrequent ras oncogene point mutations in renal cell carcinoma.

Authors:  D M Nanus; I R Mentle; R J Motzer; N H Bander; A P Albino
Journal:  J Urol       Date:  1990-01       Impact factor: 7.450

3.  Wild-type p53 can inhibit oncogene-mediated focus formation.

Authors:  D Eliyahu; D Michalovitz; S Eliyahu; O Pinhasi-Kimhi; M Oren
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

4.  Histopathology and classification of renal cell tumors (adenomas, oncocytomas and carcinomas). The basic cytological and histopathological elements and their use for diagnostics.

Authors:  W Thoenes; S Störkel; H J Rumpelt
Journal:  Pathol Res Pract       Date:  1986-05       Impact factor: 3.250

Review 5.  Tumor suppressor genes.

Authors:  R A Weinberg
Journal:  Science       Date:  1991-11-22       Impact factor: 47.728

6.  Expression of cellular oncogenes in human malignancies.

Authors:  D J Slamon; J B deKernion; I M Verma; M J Cline
Journal:  Science       Date:  1984-04-20       Impact factor: 47.728

7.  Molecular and cellular characterization of human renal cell carcinoma cell lines.

Authors:  P Anglard; E Trahan; S Liu; F Latif; M J Merino; M I Lerman; B Zbar; W M Linehan
Journal:  Cancer Res       Date:  1992-01-15       Impact factor: 12.701

8.  Characterization of an established cell line from human renal carcinoma.

Authors:  M Matsuda; M Osafune; E Nakano; T Kotake; T Sonoda; S Watanabe; T Hada; T Okochi; K Higashino; Y Yamamura; T Abe
Journal:  Cancer Res       Date:  1979-11       Impact factor: 12.701

9.  Human chromophobe cell renal carcinoma.

Authors:  W Thoenes; S Störkel; H J Rumpelt
Journal:  Virchows Arch B Cell Pathol Incl Mol Pathol       Date:  1985

10.  Expression of intermediate filament proteins in subtypes of renal cell carcinomas and in renal oncocytomas. Distinction of two classes of renal cell tumors.

Authors:  S Pitz; R Moll; S Störkel; W Thoenes
Journal:  Lab Invest       Date:  1987-06       Impact factor: 5.662

View more
  5 in total

1.  Establishment and characterization of two divergent cell lines derived from a human chromophobe renal cell carcinoma.

Authors:  C D Gerharz; R Moll; S Störkel; U Ramp; B Hildebrandt; G Molsberger; P Koldovsky; H E Gabbert
Journal:  Am J Pathol       Date:  1995-04       Impact factor: 4.307

2.  Chromophilic renal cell carcinoma: cytomorphological and cytogenetic characterisation of four permanent cell lines.

Authors:  C D Gerharz; B Hildebrandt; R Moll; U Ramp; M Sarbia; S Störkel; P Koldovsky; H E Gabbert
Journal:  Br J Cancer       Date:  1996-11       Impact factor: 7.640

3.  Mycophenolate mofetil modulates adhesion receptors of the beta1 integrin family on tumor cells: impact on tumor recurrence and malignancy.

Authors:  Tobias Engl; Jasmina Makarević; Borna Relja; Iyad Natsheh; Iris Müller; Wolf-Dietrich Beecken; Dietger Jonas; Roman A Blaheta
Journal:  BMC Cancer       Date:  2005-01-11       Impact factor: 4.430

4.  Deficient activation of CD95 (APO-1/Fas)-mediated apoptosis: a potential factor of multidrug resistance in human renal cell carcinoma.

Authors:  U Ramp; M Dejosez; C Mahotka; B Czarnotta; T Kalinski; M Wenzel; I Lorenz; M Müller; P Krammer; H E Gabbert; C D Gerharz
Journal:  Br J Cancer       Date:  2000-06       Impact factor: 7.640

5.  Apoptosis induction in renal cell carcinoma by TRAIL and gamma-radiation is impaired by deficient caspase-9 cleavage.

Authors:  U Ramp; E Caliskan; C Mahotka; A Krieg; S Heikaus; H E Gabbert; C D Gerharz
Journal:  Br J Cancer       Date:  2003-06-02       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.